SOPHiA GENETICS
Boston, MA, United States · sophiagenetics.com
SOPHiA GENETICS develops an AI-driven, cloud-based data analytics platform for healthcare. It serves providers, bioPharma, and patients in oncology, rare disorders, genomics, radiomics, and multimodal data analysis globally.
Existing clients order and track work through a login on their website. New clients start by email or their contact form; we send your request that way. Their client login
What they offer
SOPHiA DDM™ for Genomics
Computes, standardizes, and analyzes genomic and other digital health data to generate actionable insights for clinical and research use.
SOPHiA DDM™ for Radiomics
Applies AI-driven analytics to radiomics data to support precision medicine decisions.
SOPHiA DDM™ for Multimodal
Analyzes multiple health data modalities within one platform to produce actionable insights.
Professional Services
Provides enablement services, including consultation, training, implementation support, interoperability, automation, and sample sourcing.
SOPHiA DDM™ MaxCare Program
Supports labs with on-site consultation, hands-on training, performance assessments, and workflow implementation for genomics applications.
SOPHiA DDM™ Interoperability
Helps integrate advanced healthcare analytics into an institution's workflows.
SOPHiA GENETICS™ Automation
Supports workflow automation within genomics applications.
SOPHiA GENETICS™ Sample Sourcing
Provides sample sourcing support as part of the professional services suite.
What they work on
- Modalities
- genomics, radiomics, multimodal data, multiomics, NGS-based testing, liquid biopsy
- Assays and studies
- NGS-based applications, clinical trial assays, companion diagnostics
- Scale and capacity
- 2.6 million+ total genomic profiles analyzed, 660+ programs completed across 440+ institutions, ~120 days from onboarding to completion
- Therapeutic areas
- oncology, blood cancers, solid tumors, hereditary cancers, rare disorders, inherited disorders, rare and inherited disorders
- Quality
- CE-IVD (SOPHiA DDM™ Dx Hereditary Cancer Solution) · CE-IVD (SOPHiA DDM™ Dx RNAtarget Oncology Solution) · CE-IVD (SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution) · CE-IVD (SOPHiA DDM™ Dx Myeloid Solution) · CE-IVD (SOPHiA DDM™ Dx Solid Tumor Solution) · Research Use Only
- Serves
- globally, worldwide, Europe, United Kingdom, Switzerland, EEA
- Founded
- 2011
Public records
- Ownership
- SOPHiA GENETICS SA · CH GLEIF
Similar labs. AGTC Genomics, AtlasXomics, Bio-Me, Biotia
Found in a contract services directory. Listing built from sophiagenetics.com. Work here? Claim this listing.